COVID-19 Pandemic Triggers Upsurge in MBL Infections

New research has discovered that the ongoing COVID-19 pandemic has triggered a…


Infex scientists achieve breakthrough to overcome critical priority drug resistant infections

Alderley Park, Cheshire – One of the UK’s leading infectious disease biotech…


Infex scientists achieve breakthrough with potential new drug for Omicron and new coronavirus strains

Alderley Park, Cheshire –  One of the UK’s leading infectious disease biotech…


Infex Therapeutics sharpens Covid focus with new CRUK Newcastle partnership

Alderley Park, Cheshire - Infex Therapeutics is pressing ahead with a major…


Deals agreed as Infex’s resistance bypass drug program heads for clinic

Alderley Park, Cheshire Infex Therapeutics has appointed Pharmaron to help…


Infex focuses on pandemic preparedness with Covid patent

Infex Therapeutics has filed for a UK patent for a novel therapy designed to…


Infex Therapeutics and LifeArc in Collaboration to Defeat Superbugs

Infex Therapeutics has combined forces with medical research charity, LifeArc,…


The AMR Centre signs agreement to co-develop treatment for gonorrhoea

The AMR Centre (AMRC) has today announced a multi-year co-development…